IL4 and cancer: Target cancer antigens that have been investigated include CD22 [2], mesothelin [3], CD25 [4], CD30 [5], CD33 [6], Glypican 3 [7], carcinoembryonic antigen [8], and receptors for EGF [9], IL4 [10], IL6 [11], and IL13 [12].